Loading stock data…
AFL
$115.48-0.68 (-0.59%)
Pre-Market$115.47-0.02 (-0.01%)· Last close May 13
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Aflac Incorporated in the Financial Services sector is trading at $115.48. Wall Street consensus targets $111.79 (14 analysts), implying a -3.2% move over the next 12 months. The stock is currently near its 52-week high of $119.32, remaining 5.7% above its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side consensus broadly in line with current price
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JPMBACGS
Whystock Valuation Model
Sector + growth-aware fair-multiple estimate. Fair P/E = sector-anchor + (ROE × 25) + (max(revenue growth, earnings growth) × 30), capped at 1.6× sector. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. The sector anchor (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) keeps quality compounders from being mechanically penalized against utility multiples. Result is a normalised multiple gauge — not a price target.
Current Price$115.48
Potential Downside
4.9%
Whystock Fair Value$109.82
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus14 analysts
Hold
Mean target$111.79-3.2%
Range$99.00 – $126.00
Fundamentals
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, whole life, and GIFT insuran...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$60.39B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
16.89
Beta
Defensive asset. Lower volatility than the S&P 500.
0.65
Div Yield
Strong income play. Yield provides a meaningful total return floor.
213.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
8.26%
Volume
Today's trading volume
1.63M
Recent News
A Look At Aflac (AFL) Valuation After Softer Japan Margins And Quarterly Earnings Miss
Piper Sandler’s latest commentary on Aflac (AFL) followed quarterly earnings that came in below estimates, with weaker pre tax margins in Aflac Japan and two consecutive quarters of segment earnings pressure. See our latest analysis for Aflac. The recent earnings miss and softer Aflac Japan margins have not derailed the stock entirely, with a 30 day share price return of 4.93% and a 1 year total shareholder return of 12.99%, which suggests that momentum is still broadly positive over time. If...
Berkshire Hathaway Raises Japan Bet With Higher Trading House Stakes
Berkshire Hathaway lifts Sumitomo and Marubeni stakes above 10%, extending its Japan trading-house push funded by yen bonds.
Aflac (AFL) Gets Lower PT from Piper Sandler Following Quarterly Miss
With a 5-year average dividend growth rate of 14.97%, Aflac Incorporated (NYSE:AFL) is included among the 14 Best Dividend Stocks to Buy for Steady Growth. On May 1, Piper Sandler lowered its price recommendation on Aflac Incorporated (NYSE:AFL) to $125 from $130. It reiterated an Overweight rating on the shares. The firm said the company reported results […]
Are Wall Street Analysts Predicting Aflac Stock Will Climb or Sink?
Aflac has underperformed the broader market over the past year, and analysts are cautious about the stock’s prospects.
GL Stock Near 52-Week High: A Signal for Investors to Hold Tight?
Globe Life is set to grow on rising life and health premiums, stronger investment income and disciplined capital deployment.